Oral Propolis Nanoemulsions Modulate Gut Microbiota to Balance Bone Remodeling for Enhanced Osteoporosis Therapy
- 13 September 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (38) , 26153-26167
Abstract
The discovery of the bone-gut axis linking bone metabolism to gut microbiota (GM) dysbiosis has revolutionized our understanding of managing degenerative skeletal diseases. Targeting GM regulation has emerged as a promising approach to osteoporosis treatment. Herein, we develop propolis nanoemulsions (PNEs) with enhanced gastrointestinal stability and oral bioavailability for GM-based osteoporosis therapy. Orally administered PNEs exhibit superior antiosteoporosis efficacy in an ovariectomized (OVX) mouse model by modulating the GM structure and metabolites and restoring the intestinal barrier function. Multiomics analysis reveals that a reduction in Streptococcus abundance and an increase in the GM metabolite l-arginine are key factors in osteoporosis management. These changes suppress osteoclast activity and enhance osteoblast function, leading to balanced bone remodeling and, thus, significant antiosteoporotic effects via the gut-bone axis. Our results deepen insights into the intricate relationship between GM and bone remodeling, suggesting a promising strategy that maintains the homeostasis of the GM structure and metabolite for osteoporosis treatment.Keywords
Funding Information
- Science and Technology Department of Zhejiang Province (2023C03091)
- National Natural Science Foundation of China (32071349, 32371412, 52003234, 82102313, U21A20351)
- Natural Science Foundation of Zhejiang Province (LQ21E030007, LY24C100001, LY24E030002)
- Health Commission of Zhejiang Province (2023RC032, 2023RC179)
This publication has 60 references indexed in Scilit:
- Bifidobacterium lactis Probio-M8 improves bone metabolism in patients with postmenopausal osteoporosis, possibly by modulating the gut microbiotaEuropean Journal of Nutrition, 2022
- Gut Microbiota Dysbiosis as One Cause of Osteoporosis by Impairing Intestinal Barrier FunctionCalcified Tissue International, 2021
- Streptococcus pyogenes upregulates arginine catabolism to exert its pathogenesis on the skin surfaceCell Reports, 2021
- Metabolic Alterations in Older Women With Low Bone Mineral Density Supplemented With Lactobacillus reuteriJBMR Plus, 2021
- Novel O/W nanoemulsions for nasal administration: Structural hints in the selection of performing vehicles with enhanced mucopenetrationColloids and Surfaces B: Biointerfaces, 2019
- Propolis modulates the gut microbiota and improves the intestinal mucosal barrier function in diabetic ratsBiomedicine & Pharmacotherapy, 2019
- Enhanced digestion inhibition and mucus penetration of F127-modified self-nanoemulsions for improved oral deliveryAsian Journal of Pharmaceutical Sciences, 2018
- A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen SusceptibilityCell, 2016
- Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissuesAdvanced Drug Delivery Reviews, 2016
- Mutan: A mixed linkage α-[(1,3)- and (1,6)]-d-glucan from Streptococcus mutans, that induces osteoclast differentiation and promotes alveolar bone lossCarbohydrate Polymers, 2016